8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
Join Veristat and other Oncology researchers, clinicians and patients at the ESMO 2016 Conference, focused on finding the most effective cancer treatment solutions available today. ESMO 2016 offers a top-notch scientific and educational program created by international experts in oncology. Some key topic areas include:
Veristat’s Theresa Bruce and Kath Clayton will be attending ESMO and will be on hand to discuss how Veristat can help you design and execute your cancer trials throughout Europe and North America.
Veristat has helped clients run hundreds of oncology clinical trials for novel drugs, biologics, vaccines, immuno-therapies and diagnostics. We know that even the simplest of clinical trials tasks are much more complex and requires skilled expertise to complete. Schedule a time to speak with Veristat at ESMO about the challenges you are trying to overcome with your oncology program.
8 min read
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...